MedWatch

Read MedWatch's coverage of the EUHA conference

Get an overview here of what the large hearing aid manufacturers did at this year’s annual International Congress of Hearing Aid Acousticians.

Photo: EUHA/Foto Rechnitz

The International Congress of Hearing Aid Acousticians (EUHA), the world’s biggest hearing care event for audiologists and professionals, is taking place this week in Hanover, Germany.

With participation from large parts of the global hearing care sector, some of the world’s biggest hearing aid manufacturers -- including GN Hearing, Demant, and Sonova -- took to the stage to display latest product news and present them to audiologists and hearing users.

A popular topic this year was the upcoming over-the-counter hearing aid market in the US, and how different manufacturers have prepared for next week, when the sales channels opens on Monday.

International hearing conference to focus on new products in troubling times

GN Hearing

GN Hearing’s new product platform on line with predecessor, Jefferies assesses

GN Hearing has an OTC head start

GN Hearing ”satisfied” with brand presence at Costco, sees benefits of rumored new supplier opening

GN Hearing CEO: Confidence is affected when you don’t perform as expected

GN Hearing CEO: Worldwide hearing market is steady or slightly declining

Demant

Demant takes the temperature of the hearing aid market

Demant on the sidelines until OTC proves its worth

Demant’s top-line growth in line with outlook, Jefferies assesses

WS Audiology

WSA CEO: Consumers are taking longer to decide – but there is no crisis

WS Audiology boss: Strong brand and good prices are a good framework for OTC

Sony and WSA launch their first OTC hearing aids

Sonova

Sonova remains unconvinced about OTC viability

Just prior to EUHA, Sonova held an investor and analyst day at company headquarters in Stäfa, Switzerland.

Sonova in talks about rechargeability issues with large customer

Sonova is testing new model for raising listing prices

Consumers have not pivoted to cheaper alternatives, Sonova CEO says

Sonova CEO had hoped for a ”less dynamic” post-pandemic period

Sonova eyes bright future despite gloomy markets

More from MedWatch

Further reading

Latest news

See all jobs